199 related articles for article (PubMed ID: 1733082)
1. A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.
Schroeder TJ; Helling T; McKenna RM; Rush D; Jeffrey JR; Brewer B; Martin LA; Traylor D; Fisher RA; First MR
Transplantation; 1992 Jan; 53(1):34-40. PubMed ID: 1733082
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin 2 receptor (sIL-2R) levels in renal transplant recipients.
Mehta R; Shah G; Adler W; Kittur D
Clin Transplant; 2004; 18 Suppl 12():67-71. PubMed ID: 15217411
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin-2 receptor monitoring during bacterial and viral infections in liver transplant recipients: a comparative evaluation.
Rossi SJ; Schroeder TJ; Muth KL; Hanto DW; Balistreri WF; Ryckman FC
Clin Transplant; 1994 Oct; 8(5):479-84. PubMed ID: 7819615
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-2 receptor (sIL-2R) levels in renal transplantation: comparison between clinical and laboratory analysis.
Montagnino G; Tarantino A; Grignani S; Braga M; Ponticelli C
Clin Transplant; 1995 Feb; 9(1):25-30. PubMed ID: 7742579
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin-2 receptor levels measured by enzyme immunoassay in heart and kidney transplanted patients.
De Maria R; Zucchelli GC; Clerico A; Carmellini M; Di Stefano R; Masini S; Caroli A; Mian M; Bertelli A
Int J Tissue React; 1989; 11(5):261-5. PubMed ID: 2699610
[TBL] [Abstract][Full Text] [Related]
6. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
7. Differential early posttransplant cytokine responses in living and cadaver donor renal allografts.
Sadeghi M; Daniel V; Weimer R; Wiesel M; Hergesell O; Opelz G
Transplantation; 2003 Apr; 75(8):1351-5. PubMed ID: 12717229
[TBL] [Abstract][Full Text] [Related]
8. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-2 and soluble interleukin-2 receptor in renal transplant recipients.
Lee PH; Chung YC; Hu RH; Huang MT; Chao SH; Lee CJ; Lee CS
J Formos Med Assoc; 1992 Sep; 91(9):844-8. PubMed ID: 1363382
[TBL] [Abstract][Full Text] [Related]
10. Serum soluble interleukin 2 receptor (sIL-2R) as a marker of acute rejection in renal transplant children.
García-Roca P; Vargas YA; Fuentes Y; Hernández AM; Ortiz L; Valverde S; Velásquez-Jones L; Romero-Navarro B; Ramón-Garcia G; Medeiros M
Pediatr Transplant; 2012 May; 16(3):274-9. PubMed ID: 22309031
[TBL] [Abstract][Full Text] [Related]
11. Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus.
Lauzurica R; Pastor MC; Bayes B; Malumbres S; Homs M; Llopis MA; Bonet J; Romero R
Transplant Proc; 2007 Sep; 39(7):2170-2. PubMed ID: 17889127
[TBL] [Abstract][Full Text] [Related]
12. Association of high pretransplant sIL-6R plasma levels with acute tubular necrosis in kidney graft recipients.
Sadeghi M; Daniel V; Naujokat C; Mehrabi A; Opelz G
Transplantation; 2006 Jun; 81(12):1716-24. PubMed ID: 16794539
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
Remberger M; Ringdén O
Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
[TBL] [Abstract][Full Text] [Related]
14. Serial monitoring of soluble interleukin-2 receptor as a rapid marker of cytomegalovirus infection and response to antiviral therapy.
Rossi S; Schroeder T; Muth K; Hanto D; Munda R; Hariharan S; First MR; Ryckman F; Balistreri W
Clin Transplant; 1996 Feb; 10(1 Pt 1):45-50. PubMed ID: 8652897
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
16. Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation.
Foley R; Couban S; Walker I; Greene K; Chen CS; Messner H; Gauldie J
Bone Marrow Transplant; 1998 Apr; 21(8):769-73. PubMed ID: 9603399
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma].
Setoyama Y; Imai J; Ishikawa T; Sakaida H; Takaori-Kondo A; Kawamata S; Uchiyama T
Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
[TBL] [Abstract][Full Text] [Related]
19. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-2 receptor in juvenile rheumatoid arthritis.
Silverman ED; Laxer RM; Nelson DL; Rubin LA
J Rheumatol; 1991 Sep; 18(9):1398-402. PubMed ID: 1757944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]